Michael Muzengi
About Michael Muzengi
Michael Muzengi is a Global Clinical Trial Manager with extensive experience in clinical research and oncology nursing. He has worked for notable organizations including Kite Pharma, Precision For Medicine, and the Sarah Cannon Research Institute, and holds degrees from Glasgow Caledonian University and Queen Mary, University of London.
Current Role at Kite Pharma
Michael Muzengi currently serves as a Global Clinical Trial Manager at Kite Pharma. He has held this position since 2022, contributing to the management and oversight of clinical trials within the organization. His role involves coordinating various aspects of clinical research to ensure compliance with regulatory standards and the successful execution of trials.
Previous Experience in Clinical Research
Prior to his current role, Michael worked at Precision For Medicine as a Global Clinical Trial Manager from 2021 to 2022. He also held various positions at the Sarah Cannon Research Institute, including Haemato-Oncology Lead Clinical Research Nurse from 2014 to 2016 and Haemato-Oncology Clinical Research Nurse from 2012 to 2014. His experience includes significant roles at NHS, where he served as a Senior Oncology Nurse from 2006 to 2010 and as a Clinical Research Nurse from 2010 to 2012.
Experience at PRA Health Sciences
Michael Muzengi has extensive experience at PRA Health Sciences, where he worked in multiple capacities. He served as a Clinical Research Associate from 2016 to 2017, then progressed to Clinical Research Associate 2 from 2017 to 2019, and later became a Senior Clinical Research Associate from 2019 to 2021. His roles involved overseeing clinical trials and ensuring adherence to protocols and regulations.
Education and Qualifications
Michael earned a Bachelor's degree in Registered Nursing from Glasgow Caledonian University, completing his studies from 2003 to 2006. He furthered his education by obtaining a Master of Science (MSc) in Clinical Drug Development from Queen Mary, University of London, where he studied from 2013 to 2014. His educational background supports his expertise in clinical research and nursing.